<DOC>
	<DOCNO>NCT00477074</DOCNO>
	<brief_summary>The role HGF KGF COPD poorly know . Plantier et al find cultured fibroblast harvest patient emphysema produce less HGF ( similar amount KGF ) control , Bonay et al find direct relationship severity airflow obstruction HGF mRNA content lung sample smoker . These two study suggest , therefore , pulmonary regulation HGF may abnormal patient COPD . However , HGF KGF also release extra-pulmonary organ , thus potential act systemically . Given current clinical relevance attribute systemic effect COPD , study compare level HGF KGF pulmonary ( bronchoalveolar lavage ( BAL ) fluid ) systemic compartment ( circulate blood ) smoker without COPD never smoker .</brief_summary>
	<brief_title>Pulmonary Systemic Hepatocyte Growth Factors Patients With COPD</brief_title>
	<detailed_description>Background : The potential role growth factor COPD begin address recently still poorly understood . In study investigate potential abnormality hepatocyte growth factor ( HGF ) keratinocyte growth factor ( KGF ) patient COPD . Methods : To end , compare level HGF KGF , measure ELISA , bronchoalveolar lavage ( BAL ) fluid serum 18 patient COPD ( 62 ± 2 yr , FEV1 57 ± 4 % ref , X ± SEM ) , 18 smoker normal lung function ( 58 ± 2 yrs. , FEV1 90 ± 4 % ref ) 8 never smoker ( 67 ± 7 yr , 94 ± 4 % ref ) . Results : We find , BAL , HGF level higher patient COPD two group whereas , serum , HGF concentration high smoker normal lung function ( p &lt; 0.01 ) . KGF level significantly different group , neither blood BAL , ( value detection limit ) . Conclusions : These result highlight different response HGF BAL serum smoker without COPD may relevant tissue repair COPD .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Patients COPD ( GOLD IIIII ) 1 , smoker without chronic bronchitis dyspnea normal lung function , never smoker require bronchoscopy clinical purpose . Acute exacerbation last three month Chronic lung disease ( asthma , bronchiectasis interstitial lung disease ) cardiac , hepatic renal failure . Systemic steroid treatment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>chronic obstructive pulmonary disease</keyword>
	<keyword>emphysema</keyword>
	<keyword>inflammation</keyword>
	<keyword>repair</keyword>
</DOC>